Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Kidney International Reports|February 12, 2024
An Artificial Intelligence Generated Automated Algorithm to Measure Total Kidney Volume in ADPKDJonathan Taylor, Richard Thomas, Peter Metherall, et al.
Trials|February 14, 2024
HYDROchlorothiazide versus placebo to PROTECT polycystic kidney disease patients and improve their quality of life: study protocol and rationale for the HYDRO-PROTECT randomized controlled trialThomas Bais, Esther Meijer, Bart J Kramers, et al.
Kidney International Reports|June 20, 2024
Corrigendum to "An Artificial Intelligence Generated Automated Algorithm to Measure Total Kidney Volume in ADPKD" [Kidney International Reports Volume 9, Issue 2, February 2024, Pages 249-256]Jonathan Taylor, Richard Thomas, Peter Metherall, et al.
Nature Reviews. Nephrology|April 3, 2024
Chronic kidney disease and the global public health agenda: an international consensusAnna Francis, Meera N Harhay, Albert C M Ong, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 25, 2016
Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best PracticeRon T Gansevoort, Mustafa Arici, Thomas Benzing, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 19, 2019
Small-molecule allosteric activators of PDE4 long form cyclic AMP phosphodiesterasesFaisa Omar, Jane E Findlay, Gemma Carfray, et al.
Trials|November 25, 2017
Standardised Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD): study protocol for establishing a core outcome set in polycystic kidney diseaseYeoungjee Cho, Benedicte Sautenet, Gopala Rangan, et al.
Kidney International|December 26, 2019
Detection and characterization of mosaicism in autosomal dominant polycystic kidney diseaseKatharina Hopp, Emilie Cornec-Le Gall, Sarah R Senum, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 8, 2022
An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease InternationalRoman-Ulrich Müller, A Lianne Messchendorp, Henrik Birn, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 28, 2024
Clinical Spectrum and Prognosis of Atypical Autosomal Dominant Polycystic Kidney Disease Caused by Monoallelic Pathogenic Variants of IFT140Nikola Zagorec, Alizée Calamel, Margaux Delaporte, et al.
Pageof 11